FlorentLe Prado

Associate

Paris + 33.1.56.59.38.04

Florent Le Prado's areas of practice include venture capital, private equity, M&A, and capital markets.

He primarily represents high-growth listed and unlisted companies, their managers, and the private equity and industrial investors that finance them at every stage of development from entrepreneurial start-ups to global corporations.

Florent's recent experience includes representing technology and life sciences companies, including Welcome to the Jungle, Ivalua, Adikteev, SuperSonic Imagine, TxCell, Pharnext, Inside Secure, Diaxonhit, Alizé Pharma, and Cellectis. His recent investor-side representations include Alven Capital Partners, Bpifrance Investissement, Creadev (Mulliez family), Ring Capital, Idinvest Partners, Elaia Partners, and Seventure Partners.

Illustrative transactions in which Florent has advised include the tender offers on SuperSonic Imagine, Coheris, and TxCell; the IPOs of Medincell and Pharnext; the LBO of Brico Privé by Florac; the latest financing rounds of Welcome to the Jungle, Ivalua, Foodles, Malt, InnovaFeed, Linkfluence, Actility, and Younited Credit; the acquisition of Elium by eMoteev (Adikteev Group); the sale of Alizé Pharma to Millendo Therapeutics; and the issue of convertible bonds (Oceanes) by Inside Secure.

Experience

  • SuperSonic Imagine acquired by Hologic, Inc.Jones Day advised Supersonic Imagine and its main shareholders in connection with the acquisition of a controlling stake followed by a tender offer by Hologic, Inc. based on an enterprise value of circa US$85 million.
  • Creadev, DN Capital, and Adelie invest €9 million in FoodlesJones Day represented Creadev SAS, DN Capital, and Adelie in connection with the €9 million (US$10 million) round of financing of Foodles, a French company providing canteen-like services using connected fridges and daily deliveries.
  • Ivalua raises $60 million in financing roundJones Day represented Ivalua SAS, a leading provider of global spend management cloud solutions, in connection with its $60 million round of financing led by Tiger Global Management.
  • Idinvest Partners participates in €25 million investment in MaltJones Day represented Idinvest Partners SA in connection with the €25 million (US$28.5 million) round of financing of Malt, a French-based company that develops a marketplace connecting freelances with companies.
  • Dolmen raises €9 million in financing roundJones Day represented Dolmen, a French-based company that designs and develops a local customer marketing platform, in connection with its €9 million (US$10.2 million) round of financing led by Mediapost, Salesforce Ventures, and Kreaxi.
  • Creadev invests in InnovaFeedJones Day represented Creadev and Temasek in connection with their investment in InnovaFeed, a biotech company producing high quality insect meals for the feed industry.
  • Bryan Garnier & Co Ltd and Crédit Agricole Corporate and Investment Bank complete €30 million IPO on Euronext by MedinCellJones Day represented Bryan Garnier & Co Ltd and Crédit Agricole Corporate and Investment Bank, as joint global coordinators and joint bookrunners, in connection with the €30 million (US$34.4 million) initial public offering of Ordinary Shares on the regulated market of Euronext in Paris by MedinCell, a developer of next generation of best-in-class medicine.
  • Ring participates in €18 million financing round of LinkfluenceJones Day advised Ring SAS in connection with the €18 million (US$21 million) financing round of Linkfluence, a leading social data intelligence company that offers unique solutions for the monitoring, analysis, and activation of social media channels.
  • Ring invests in DoleadJones Day advised Ring SAS in connection with the $15 million round of financing of Dolead, a company specialized in machine learning technology based on a “semantic graph” that creates and updates online advertising campaigns.
  • Brico Privé sold to Florac InvestissementsJones Day advised Brico Privé SAS, the leading French online flash sales platform dedicated to do-it-yourself (DIY), gardening and home-improvement, its management, and Ardian in connection with the leveraged buy-out of Brico Privé by Florac Investissements.
  • Alizé Pharma SAS acquired by Millendo Therapeutics, Inc.Jones Day advised Alizé Pharma SAS, a French clinical-stage biotech private company, in connection with its sale in a stock-for-stock transaction to Millendo Therapeutics, Inc., a U.S. clinical-stage biotech private company focused on developing novel treatments for endocrine diseases.
  • Bpifrance further invests in DoctolibJones Day represented Bpifrance in connection with its investment in Doctolib, a developer and marketer of an online booking platform and management software for doctors in Europe.
  • Alven Capital invests in MeeroJones Day advised Alven Capital Partners in connection with the €15 million round of financing of Meero, one of the leading players in the field of photography production.
  • Bpifrance invests in Younited CréditJones Day advised Bpifrance in connection with the €40 million round of financing of Younited Crédit, a leading online consumer lending platform in Continental Europe.
  • Inside Secure completes €15 million bonds offeringJones Day advised Inside Secure, a leader in embedded security solutions for mobile and connected devices, in connection with its private placement of bonds convertible into new shares and/or exchangeable for existing shares for a nominal amount of approximately €15 million.
  • Alven Capital, Idinvest Partners, and Korelya Capital invest in JobteaserJones Day advised Alven Capital Partners, Idinvest Partners, and Korelya Capital in connection with the €15 million financing round of Jobteaser, a developer of digital recruitment solutions.
  • Creadev invests in ActilityJones Day advised Creadev (famille Mulliez) in connection with the $75 million Series D financing round of Actility, a leading provider of global internet of things solutions.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.